Article Details

Incannex granted meeting with FDA over CBD drug cocktail

Retrieved on: 2021-03-26 00:33:45

Tags for this article:

Click the tags to see associated articles and topics

Incannex granted meeting with FDA over CBD drug cocktail. View article details on hiswai:

Excerpt

Special Report: Incannex Healthcare (ASX:IHL) is making steady progress on its hydroxychloroquine (HCQ)/cannabidiol (CBD) drug combination and ...

Article found on: stockhead.com.au

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up